United Therapeutics is in the news for pioneering pig organ transplants and gene-edited pig livers, pushing biotech’s animal-to-human frontier.
United Therapeutics announced the first successful pig kidney transplant at NYU Langone, marking a key step in xenotransplantation. The trial involved gene-edited pig kidneys and could expand if successful. Other companies are preparing similar trials amid mixed results from earlier experiments. The goal is to address organ shortages.